CIK 0001588978 · Large accelerated filer
PROCEPT BioRobotics Corp
Sign in to watch- Ticker
- PRCT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260199180
- Phone
- 6502329832
- Business address
- 150 BAYTECH DRIVE, SAN JOSE, CA, 95134
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $114,707
- in 4 filings
Net −$114,707. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-06 | Zadno Reza President, CEO | Grant or award | +48,575 | 249,531 | ||
| 2024-03-06 | Zadno Reza President, CEO | Grant or award · Stock Option (Right to Buy) | +42,311 | 42,311 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award | +13,275 | 46,798 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award · Stock Option (Right to Buy) | +11,563 | 11,563 | ||
| 2024-03-06 | Nouri Alaleh EVP, CLO, CORP. SEC. | Grant or award | +18,311 | 65,662 | ||
| 2024-03-06 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale | −2,749 | $46.67 | $128K | 62,913 |
| 2024-03-06 | Nouri Alaleh EVP, CLO, CORP. SEC. | Grant or award · Stock Option (Right to Buy) | +15,949 | 15,949 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award | +19,328 | 52,851 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Sale | −3,435 | $46.67 | $160K | 49,416 |
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award · Stock Option (Right to Buy) | +16,835 | 16,835 | ||
| 2024-03-06 | Zadno Reza President, CEO | Grant or award | +54,933 | 255,889 | ||
| 2024-03-06 | Zadno Reza President, CEO | Sale | −9,179 | $46.67 | $428K | 246,710 |
| 2024-03-06 | Zadno Reza President, CEO | Grant or award · Stock Option (Right to Buy) | +47,849 | 47,849 | ||
| 2024-03-06 | Shiblaq Hisham EVP, Chief Comm. Officer | Grant or award | +26,449 | 57,863 | ||
| 2024-03-06 | Shiblaq Hisham EVP, Chief Comm. Officer | Sale | −1,759 | $46.67 | $82K | 56,104 |
| 2024-03-06 | Shiblaq Hisham EVP, Chief Comm. Officer | Grant or award · Stock Option (Right to Buy) | +23,038 | 23,038 | ||
| 2024-03-04 | Krummel Thomas M Director | Sale 10b5-1 | −11,762 | $48.21 | $567K | 73,869 |
| 2024-03-04 | Krummel Thomas M Director | Sale 10b5-1 | −8,238 | $48.99 | $404K | 65,631 |
| 2024-02-12 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +22,349 | $4.52 | $101K | 55,872 |
| 2024-02-12 | Waters Kevin EVP, CFO | Sale 10b5-1 | −22,349 | $50.16 | $1.1M | 33,523 |
Page 14 of 25 · 483 trades